Best J M, Banatvala J E, Bowen J M
Br Med J. 1974 Jul 27;3(5925):221-4. doi: 10.1136/bmj.3.5925.221.
A total of 142 seronegative volunteers were given one of the following rubella vaccines: Cendehill, HPV77. DE-5, RA27/3, or a new Japanese vaccine, To-336. To-336 vaccine produced a slightly higher geometric mean antibody titre (G.M.T.) (65.7) than did the HPV77. DE-5 (63.1) or RA27/3 vaccine (61.9) but the G.M.T. induced by Cendehill vaccine was much lower (39.3).Reactions, particularly joint symptoms, occurred least commonly after vaccination with To-336 vaccine. Joint symptoms occurred within seven days of menstruation in 30 out of 37 (81%) vaccines (P <0.01); their incidence was not related to oral contraception.Though there is evidence to suggest that Japanese virus strains may be non-teratogenic further data on the incidence of congenitally acquired infection in Japan must be collected before this conclusion can be supported on epidemiological grounds.
总共142名血清反应阴性的志愿者接种了以下风疹疫苗之一:Cendehill、HPV77、DE-5、RA27/3或一种新的日本疫苗To-336。To-336疫苗产生的几何平均抗体滴度(G.M.T.)(65.7)略高于HPV77、DE-5(63.1)或RA27/3疫苗(61.9),但Cendehill疫苗诱导的G.M.T.要低得多(39.3)。接种To-336疫苗后反应,尤其是关节症状,出现得最少。37名接种疫苗者中有30名(81%)在月经七天内出现关节症状(P<0.01);其发生率与口服避孕药无关。虽然有证据表明日本病毒株可能无致畸性,但在基于流行病学依据支持这一结论之前,必须收集日本先天性感染发生率的更多数据。